SARS-CoV-2

Clinical information

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously called 2019-nCoV) belongs to the family of coronaviruses and, like SARS-CoV, is classified in the genus Betacoronavirus. At the end of 2019, SARS-CoV-2 caused an infection wave which quickly spread worldwide and was declared a pandemic by the WHO in March 2020. Just a few days after the first report about patients with pneumonia of unclear origin, SARS-CoV-2 was identified as the causative pathogen and the associated disease named COVID-19.

SARS-CoV-2 is mainly transmitted via aerosols during speaking, breathing, coughing or sneezing or at close contact with an infected person. The incubation period is three to seven, maximally 14 days. The symptoms and severity of SARS-CoV-19 infection can vary significantly. The most common symptoms encompass fever, coughing, breathing difficulties and fatigue. Therefore, in the majority of patients, the infection resembles a cold with light fever, with irregular lung infiltrates. Some patients, especially older and chronically ill persons, develop severe acute respiratory distress syndrome.

Diagnostics

Suitable methods for the diagnosis of SARS-CoV-2 infections are the detection of viral RNA by reverse transcriptase polymerase chain reaction (RT-PCR) or of virus protein by means primarily in sample material from the upper (nasopharyngeal or oropharyngeal swab) or lower respiratory tract (bronchoalveolar lavage fluid, tracheal secretion, sputum, etc.). The RT-PCR allows detection of the pathogen even in subclinical or asymptomatic courses already few days after virus contact and up to 14 after onset of possible symptoms.

The EURORealTime-SARS-CoV-2 test and the EURORealTime SARS-CoV-2 Fast test enable highly specific and sensitive direct detection of SARS-CoV-2 by means of reverse-transcriptase real-time PCR. Reverse transcription, amplification and detection of the SARS-CoV-2 cDNA are performed by means of specific primers and probes. In addition, the EURORealTime SARS-CoV-2 Fast provides comes with a time-saving RT-PCR protocol that enables detection within about 45 minutes (depending on the type of device).

For differential diagnostics of symptoms which can be associated both with COVID-19 and Influenza, EUROIMMUN offers a combined tests for the parameters SARS-CoV-2, Influenza virus type A and Influenza virus type B: EURORealTime SARS-CoV-2/Influenza A/B.

Optionally, the EURORealTime Analysis software supports the analysis and evaluation of the data, the generation of result reports and the electronic archiving of the results including all internal and external controls. The data processing steps required in real-time PCR are thus significantly simplified and accelerated. The software also provides convenient guidance through the entire work procedure, thus preventing the occurrence of errors.

Moreover, the EUROIMMUN product portfolio for COVID-19 diagnostics encompasses serological tests for differentiated detection of antibodies of different immunoglobulin classes and against different SARS-CoV-2 antigens and an antigen ELISA for acute diagnostics.

Please find further information and details on our SARS-CoV-2 tests systems here www.coronavirus-diagnostics.com.

Selected Products

Method
Parameter
Substrate
EUROLINE
Positive control serum (IgG, 50x concentrated)
for SARS CoV-2
ELISA
SARS-CoV-2
antigen-coated
microplate wells
ELISA
SARS-CoV-2 Antigen
ELISA
Quan-T-Cell SARS-CoV-2
To be used in combination with EQ 6841
PCR
EURORealTime SARS-CoV-2
EUROLINE
EUROLINE Anti-SARS-CoV-2 Profile ( IgG)
EUROLINE
ChLIA
SARS-CoV-2 RBD
ChLIA
Control set
Anti-SARS-CoV-2 RBD ChLIA (IgG)
ELISA
SARS-CoV-2 QuantiVac
ELISA
SARS-CoV-2 NCP
ChLIA
IDS SARS-CoV-2 S1-RBD Kontrollset
ChLIA
IDS SARS-CoV-2 S1-RBD IgG
PCR
EURORealTime SARS-CoV-2/Influenza A/B
ELISA
SARS-CoV-2 (Omicron Variante)
ELISA
SARS-CoV-2 NeutraLISA
PCR
EURORealTime SARS-CoV-2 Fast
ELISA
Quan-T-Cell ELISA
To be used in combination with ET 2606
antibody-coated
microplate wells
Back to top
Contact person on site
Please click on a country or enter yours
North America
South & Central America
Europe
Asia
Oceania
Middle East & Africa
  • North America
  • South & Central America
  • Europe
  • Asia
  • Oceania
  • Middle East & Africa